Zurich adds products liability coverage for life sciences companies

Zurich North America said Tuesday it will launch products liability for life sciences for pharmaceutical, medtech, research and development, and other companies with revenue up to $1 billion.

The primary products liability coverage offers limits up to $10 million and is designed for life sciences companies such as those in pre-clinical and clinical R&D; pharmaceuticals and biologics; medtech and medical devices; contract manufacturing; contract research; and wholesale and distribution, Zurich North America said in a statement.

The coverage is designed to address four main needs: products-completed operations liability; errors and omissions; professional services liability; and clinical trials, the statement said.

Companies also can consider flexible options such as worldwide territory built into the form, automatic additional insureds, and extended reporting periods for specific exposures.